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Abrial	Cooke	
Time	Will	Tell:	The	Involvement	of	the	Circadian	Clock	in	Colorectal	Cancer 
A	 circadian	 rhythm	 is	 a	 24	 hour	 recurring	 biological	 process.	 A	 group	 of	 core	
genes	 and	 transcription	 factors	 (CLK,	 BMAL1,	 PER,	 CRY)	 called	 the	 circadian	 clock	
regulates	 these	 24	 hour	 rhythms	 through	 a	 transcription/translation	 feedback	 loop.	
Over	 40%	 of	 the	 genome	 is	 transcribed	 rhythmically	 implicating	 the	 clock	 in	 many	
cellular	processes.	Recently,	it	has	been	shown	that	WNT,	a	mediator	of	intestinal	stem	
cell	proliferation	 is	transcribed	rhythmically.	Uncontrolled	cell	proliferation	can	 lead	to	
cancer,	which	is	seen	with	the	mutation	of	APC,	a	regulator	of	Wnt	mutated	in	80%	of	all	
colorectal	cancer	cases.	Colorectal	cancer	incidence	has	been	steadily	increasing	due	to	
chronic	 photoperiod	 disruptions	 such	 as	 shift	work.	My	 project	will	 examine	 how	 the	
disruption	of	the	circadian	clock	in	the	intestine	affects	cancer	incidence.	I	hypothesize	
that	a	dysfunctional	clock	will	lead	to	enhanced	tumorigenesis.	Due	to	the	implication	of	
APC	 in	 colorectal	 cancer,	we	will	 use	 a	mouse	 that	 is	 heterozygous	 for	 the	APC	 gene,	
APCmin/+	 to	 model	 colorectal	 cancer	 in	 a	 mouse.	 I	 will	 compare	 APCmin/+;	 BMAL1+/+	
intestines,	which	have	a	normal	circadian	clock,	to	APCmin/+;	BMAL1-/-	 intestines,	where	
the	 clock	 is	 dysfunctional.	 I	will	 count	 polyps,	 and	 use	H&E	 stained	 tissue	 sections	 to	
quantify	the	size	of	each	tumour.	The	Wnt	pathway,	cell	cycle	activity	and	the	circadian	
clock	will	 be	 examined	 using	 immunofluorescence	 to	 study	 the	 potential	 relationship	
between	cancer	development	and	the	clock.	PER2,	a	core	clock	protein	as	well	as	cMYC,	
a	Wnt	 target	will	be	 investigated.	 I	predict	 that	 the	APCmin/+;	BMAL1+/+	mice,	will	have	
fewer	tumors	than	the	APCmin/+;	BMAL1-/-.	My	preliminary	data	shows	that	the	APCmin/+;	
BMAL1+/+	 tissue	 has	 more	 tumours	 than	 APC+/+;	 BMAL1+/+	 suggesting	 this	 colorectal	
mouse	model	works.	 Implicating	the	circadian	clock	 in	colorectal	cancer	may	allow	for	
greater	understanding	in	how	to	treat	or	avoid	it. 
 
 
